Our attorneys are investigating legal claims on behalf of investors of Natus Medical (NASDAQ: BABY) regarding possible violations of federal securities laws.

Invest in Natus Medical (NASDAQ: BABY)?

You may have a legal claim.  Speak to an attorney about your rights.

  • This field is for validation purposes and should be left unchanged.

1-800-808-5294

Natus Medical Stock Drops Following Publication of GlassHouse Report Alleging Accounting Misconduct

On February 6, 2019, GlassHouse Research published a report about Natus Medical (NASDAQ: BABY), claiming that the company concealed accounting information. The report estimated $18 million in obsolete inventory that the company will need to write off in 2019, in addition to possible SEC fines. It calls Natus Medical’s inventory diagnostics “one of the worst we have ever seen when analyzing public companies,” and compares Natus’s current situation to Logitech, which agreed to pay a multimillion dollar accounting penalty in 2016.

On this news, Natus Medical shares dropped 3.14% to $30.51 on February 7, 2019.

Gibbs Law Group's Financial Fraud Experience

Gibbs Law Group’s financial fraud and securities lawyers have more than two decades of experience prosecuting fraud. Our attorneys have successfully litigated against some of the largest companies in the United States, and we have recovered more than a billion dollars on our clients’ behalf.

We have fought some of the most complex cases brought under federal and state laws nationwide, and our attorneys have been recognized with numerous awards and honors for their accomplishments, including Top 100 Super Lawyers in Northern California, Top Plaintiff Lawyers in California, The Best Lawyers in America, and rated AV Preeminent (among the highest class of attorneys for professional ethics and legal skills).

Noteworthy Financial Fraud Cases

American Express Financial Advisors Securities Litigation $100 million cash settlement for clients alleging American Express steered them into under-performing “shelf space funds” to reap kickbacks
Chase Bank “Check Loan” Litigation $100 million settlement for consumers alleging Chase offered long-term fixed-rate loans, only to later more-than-double required payments
Peregrine Financial Group Customer Litigation Settlements worth $75 million for futures and commodities investors who lost millions in the collapse of Peregrine Financial Group, Inc.
NantHealth Court-appointed Co-Lead Counsel in a securities class action alleging the company’s founder violated federal securities law and artificially inflated stock prices

Our Securities Attorneys

Eric Gibbs

Eric has served in leadership positions in a number of high profile, complex financial lawsuits. He has been recognized as a Daily Journal, among the Top 100 Super Lawyers in Northern California, and a Law360 MVP for Consumer Protection.

David Stein

David’s advocacy has generated major recoveries for consumers impacted by financial fraud. He was named to the Top 40 Under 40 by Daily Journal and a “Rising Star in Class Actions” by Law360.

Michael Schrag

Michael has over 20 years of experience representing individuals in complex cases involving banking credit card and other financial frauds.

Amanda Karl

Amanda represents employees, consumers and investors in complex class action lawsuits throughout the country. She previously served as a law clerk to the Honorable Richard A. Paez, United States Court of Appeals for the Ninth Circuit, and to the Honorable Claudia Wilken, Northern District of California.

BABY stock losses?

Speak to a securities attorney to recover your money. Free, confidential consultations.

  • This field is for validation purposes and should be left unchanged.

1-800-808-5294